5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects.
M Coppola, R Mondola
Index: Toxicol. Lett. 218(1) , 24-9, (2013)
Full Text: HTML
Abstract
In 2010, an internet snapshot of EMCDDA anticipated the presence of 5-iodo-2-aminoindan (5-IAI) within the recreational drug market. In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p-iodoamphetamine producing MDMA-like effects. The aim of this paper is to summarize the clinical, pharmacological, and toxicological information about this new potential drug of abuse.Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Related Compounds
Related Articles:
Additive inhibition of human α1β2γ2 GABAA receptors by mixtures of commonly used drugs of abuse.
2013-03-01
[Neurotoxicology 35 , 23-9, (2013)]
2011-04-01
[J. Anal. Toxicol. 35(3) , 162-9, (2011)]
Urinary excretion profiles of N-hydroxy-3,4-methylenedioxymethamphetamine in rats.
2011-07-01
[Xenobiotica 41(7) , 578-84, (2011)]
2012-10-10
[Forensic Sci. Int. 222(1-3) , e1-6, (2012)]
2012-11-01
[Anal. Bioanal. Chem 404(8) , 2427-35, (2012)]